AstraZeneca confirms vaccine now renamed ‘Vaxzevria’

GLOBAL Media Relations Director for AstraZeneca Kim Blomley has confirmed that the company has renamed its COVID-19 vaccine in conjunction with the British University of Oxford.

Blomley, in a conversation with The ICIR on Saturday, stated that the vaccine had been renamed ‘Vaxzevria,’ adding that the name was only for the European Union.

“The product name has changed – but only for the EU as registered with the European Medical Authority,” said Blomley.

Blombley noted that the new name had been planned for many months before its implementation, saying it did not change the vaccine’s policy and supply.

“The use of the brand name does not signify any changes in AstraZeneca’s policy to supply the vaccine at no-profit during the pandemic.”

Blombley said the change to a permanent trade name was customary and did nothing to the product.

“For instance, Pfizer/Biontech’s BNT162b2 is now COMIRNATY in the EU,” Blombley added.



    The EMA had stated that the Vaxzevria vaccine was safe in people over 18 years of age, but had reduced its effectiveness from 79 to 76 percent.

    The ICIR had reported how Nigeria took the delivery of 3.9 million doses of the vaccine in March.

    Germany, France, Thailand, 15 others countries have  suspended the administration of the vaccine over growing concerns of blood clots.  However, many countries now accept its use.

    The World Health Organization(WHO) and European regulators have continued to express confidence in its safety.

    'Niyi worked with The ICIR as an Investigative Reporter and Fact-checker from 2020 till September 2022. You can shoot him an email via [email protected]. You can as well follow him on Twitter via @niyi_oyedeji.

    Join the ICIR WhatsApp channel for in-depth reports on the economy, politics and governance, and investigative reports.

    Support the ICIR

    We invite you to support us to continue the work we do.

    Your support will strengthen journalism in Nigeria and help sustain our democracy.

    If you or someone you know has a lead, tip or personal experience about this report, our WhatsApp line is open and confidential for a conversation


    Please enter your comment!
    Please enter your name here

    Support the ICIR

    We need your support to produce excellent journalism at all times.

    - Advertisement


    - Advertisement